Presented ByDr Catherine Diefenbach, NYU Langone Health, NY, USA
TrialPhase 1, BO42203 ConferenceASH 2024
TypePeer-reviewed article
29 January 2025 10:29
Presented ByDr Ghayas Issa, MD Anderson Cancer Center, TX, USA
TrialPhase 1/2, SAVE ConferenceASH 2024
TypePeer-reviewed article
29 January 2025 10:17
Presented ByDr Daniel Pollyea, University of Colorado, CO, USA
ConferenceASH 2024
TypePeer-reviewed article
29 January 2025 10:14
Presented ByDr Jennifer Marvin-Peek, MD Anderson Cancer Center, TX, USA
TrialPhase 1/2 ConferenceASH 2024
TypePeer-reviewed article
29 January 2025 10:12
Presented ByDr Ioannis Mantzaris, Montefiore Medical Center, NY, USA
TrialPhase 1 ConferenceASH 2024
TypePeer-reviewed article
29 January 2025 10:07
Presented ByProf. Paolo Ghia, University Vita-Salute San Raffaele, Italy
TrialPhase 3, SEQUOIA ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 14:27
Presented ByDr Wei-Ying Jen, MD Anderson Cancer Center, TX, USA
TrialPhase 2 ConferenceEHA 2024
TypePeer-reviewed article
12 August 2024 14:20
Presented ByDr Musa Yilmaz, MD Anderson Cancer Center, TX, USA
TrialPhase 1/2 ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 15:04
Presented ByDr Xiaoyuan Gong, Chinese Academy of Medical Sciences, China
TrialPhase 2 ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 15:02
Presented ByDr Moritz Fürstenau, University of Cologne, Germany
TrialPhase 2, CLL2-BAAG ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 15:01
Presented ByProf. Michael Wang, University of Texas, TX, USA
TrialPhase 3, SYMPATICO ConferenceASH 2023
TypePeer-reviewed article
7 February 2024 14:59
Presented ByProf. John Allan, Weill Cornell Medicine, NY, USA
TrialPhase 2, CAPTIVATE ConferenceASH 2022
TypePeer-reviewed article
20 February 2023 11:28
Presented ByProf. Nicholas Short, University of Texas, TX, USA
ConferenceASH 2022
TypePeer-reviewed article
20 February 2023 11:25
Presented ByMr Jad Othman, Guy’s and St Thomas’ NHS Foundation Trust, UK
ConferenceASH 2022
TypePeer-reviewed article
20 February 2023 11:20
Presented ByProf. Naval Daver, Anderson Cancer Center, TX, USA
TrialPhase 3, ENHANCE-3 ConferenceASH 2022
TypePeer-reviewed article
20 February 2023 11:17
Presented ByProf. Barbara Eichhorst, University Hospital Cologne, Germany
TrialPhase 3, GAIA/CLL13 ConferenceEHA 2022
TypeNews article
1 July 2022 11:43
Presented ByDr Naval Daver, MD Anderson Cancer Center, TX, USA
TrialPhase 1/2 ConferenceASH 2021
TypePeer-reviewed article
4 February 2022 11:49
Presented ByDr Patrick Reville, MD Anderson Cancer Center, TX, USA
TrialPhase 2 ConferenceASH 2021
TypePeer-reviewed article
4 February 2022 11:48
Presented ByDr Musa Yilmaz, MD Anderson Cancer Center, TX, USA
ConferenceASH 2021
TypePeer-reviewed article
4 February 2022 11:46
Presented ByDr Paolo Ghia, Università Vita-Salute San Raffaele, Italy
TrialPhase 2, CAPTIVATE ConferenceASH 2021
TypePeer-reviewed article
4 February 2022 11:41
Presented ByDr Meghan Thompson, Memorial Sloan Cancer Center, NY, USA
ConferenceASH 2021
TypePeer-reviewed article
4 February 2022 11:36
ExpertDr Jennifer Woyach, Ohio State University, OH, USA
TrialPhase 3, Alliance A041202 ConferenceASH 2021
3 February 2022 23:22
ExpertDr. Talha Munir, Leeds Teaching Hospitals NHS Trust, UK
TrialPhase 3, GLOW ConferenceASH 2021
3 February 2022 23:15
ExpertProf. Paolo Ghia, Università Vita-Salute San Raffaele, Italy
TrialPhase 2, CAPTIVATE ConferenceASH 2021
20 January 2022 16:29
Presented ByDr Rachel Giles, Medicom
ConferenceASH 2021
4 January 2022 08:00
Presented ByDr Mark-David Levin, Albert Schweitzer Hospital, the Netherlands
TrialPhase 2, HOVON 139/GiVe ConferenceEHA 2021
TypePeer-reviewed article
5 August 2021 13:38
Presented ByProf. Arnon Kater, Amsterdam University Medical Centres, the Netherlands
TrialPhase 2, GLOW ConferenceEHA 2021
TypePeer-reviewed article
5 August 2021 13:33
Presented ByDr Shukaib Arslan, City Of Hope Helford Clinical Research Hospital, California, USA
ConferenceASH 2020
TypePeer-reviewed article
18 February 2021 09:19
Presented ByDr Tapan Kadia, MD Anderson Cancer Center, Texas, USA
ConferenceASH 2020
TypePeer-reviewed article
18 February 2021 09:05
Presented ByDr Courtney Di Nardo, MD Anderson Cancer Centre, USA
TrialPhase 3, VIALE-A ConferenceEHA 2020
TypePeer-reviewed article
9 September 2020 13:25
Presented ByProf. Andrew Wei, Monash University, Australia
TrialPhase 3, VIALE-C ConferenceEHA 2020
TypePeer-reviewed article
9 September 2020 13:22
Presented ByDr Abhishek Maiti, University of Texas MD Anderson Cancer Centre, USA
TrialPhase 2 ConferenceEHA 2020
TypePeer-reviewed article
9 September 2020 13:18
ExpertProf. Arnon Kater, Amsterdam University Medical Center, the Netherlands
TrialPhase 3, VENICE 1 ConferenceEHA 2020
TypePeer-reviewed article
9 September 2020 11:35
Presented ByProf. Elias Jabbour , University of Texas MS Anderson Cancer Centre, USA
TrialPhase 1 ConferenceEHA 2020
TypePeer-reviewed article
28 August 2020 12:23
Presented ByDr Eugen Tausch, University of Ulm, Germany
TrialCLL14 ConferenceEHA 2019
TypePeer-reviewed article
9 August 2019 22:38
Presented ByDr Shaji Kumar, Mayo Clinic, USA
TrialPhase 3, BELLINI ConferenceEHA 2019
TypePeer-reviewed article
9 August 2019 09:42
Presented ByDr Kirsten Fischer, University of Cologne, Germany
TrialPhase 3, CLL14 ConferenceEHA 2019
TypePeer-reviewed article
9 June 2019 23:28